RxDoctor Payments Data

Justin Haslam, NP

Family · Ogden, UTNPI 1033729512

Payments from drug & device makers

$4,478in general payments, 2019–2025

Across 276 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$577
  • Pfizer$270
  • Amgen$245
  • GSK$241
  • Amarin Pharma, Inc.$202
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,478100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,478 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$75,217
Medicare patients
327
Services billed
2,355

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide41$46,937
JardianceEmpagliflozin27$40,323
EliquisApixaban39$36,844
TrulicityDulaglutide21$25,219
OzempicSemaglutide25$21,114
MyrbetriqMirabegron18$15,126
Stiolto RespimatTiotropium Br/Olodaterol Hcl20$14,806
XareltoRivaroxaban13$12,978
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,649
LinzessLinaclotide13$9,517
Testosterone24$4,624
SymbicortBudesonide/Formoterol Fumarate11$3,202
Albuterol Sulfate HfaAlbuterol Sulfate84$2,704
Atorvastatin Calcium210$2,086
Esomeprazole Magnesium26$2,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$577$72,15662 claims
Boehringer IngelheimJardiance, Stiolto Respimat$109$55,12947 claims
PfizerEliquis$270$36,84439 claims
Novo NordiskOzempic$97$21,11425 claims
Astellas Pharma US IncMyrbetriq$31$15,12618 claims
AstraZenecaBreztri Aerosphere, Symbicort$184$13,85122 claims
Johnson & JohnsonXarelto$169$12,97813 claims
AbbVieLinzess$1,062$9,51713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,460 family providers in Utah.

Other family in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →